Webinar: Update on the Perinatal Guidelines
Facilitated by Marylee Worley, PharmD, BCPS
Faculty, South Florida- Southeast AIDS Education &Training Center
Assistant Professor, Pharmacy Practice
Clinical Pharmacist, Infectious Diseases
Nova Southeastern University, College of Pharmacy
August 29, 2018
Objectives
- Describe the current guideline recommendations for management of ARV therapy during pregnancy and at birth
- Describe the recommendations regarding the use of dolutegravir in adults and adolescents with HIV who are pregnant or of child-bearing potential
- List alternative ARV options for women of childbearing potential prescribed dolutegravir.
Presentation
Slides
Facilitated by Marylee Worley, PharmD, BCPS
Faculty, South Florida- Southeast AIDS Education &Training Center
Assistant Professor, Pharmacy Practice
Clinical Pharmacist, Infectious Diseases
Nova Southeastern University, College of Pharmacy
August 29, 2018
Objectives
- Describe the current guideline recommendations for management of ARV therapy during pregnancy and at birth
- Describe the recommendations regarding the use of dolutegravir in adults and adolescents with HIV who are pregnant or of child-bearing potential
- List alternative ARV options for women of childbearing potential prescribed dolutegravir.
Presentation
Slides
Facilitated by Marylee Worley, PharmD, BCPS
Faculty, South Florida- Southeast AIDS Education &Training Center
Assistant Professor, Pharmacy Practice
Clinical Pharmacist, Infectious Diseases
Nova Southeastern University, College of Pharmacy
August 29, 2018
Objectives
- Describe the current guideline recommendations for management of ARV therapy during pregnancy and at birth
- Describe the recommendations regarding the use of dolutegravir in adults and adolescents with HIV who are pregnant or of child-bearing potential
- List alternative ARV options for women of childbearing potential prescribed dolutegravir.
